|Last Price||Today's Change||52-Week Range||Trading Volume|
|89.75||-0.29 (-0.32%)||74.10 - 154.89||1.4 million (Below Avg)|
Market data as of 3:59PM 04/17/14. Quotes are delayed by at least 15 min.
BioClinica Technology Supports Pharmacyclics in Achieving Early Approval of IMBRUVICA™ and Breakthrough Therapy Designations for Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL)
03/11/2014 9:00 AM ET